Literature DB >> 25819883

The association between intradialytic exercise and hospital usage among hemodialysis patients.

Kristen Parker1, Xin Zhang, Adriane Lewin, Jennifer M MacRae.   

Abstract

Hemodialysis (HD) patients have high hospitalization rates. Benefits of intradialytic exercise have been proven in numerous studies yet exercise programs are still rarely used in the treatment of end-stage kidney disease (ESKD). Our objective was to determine if there was an association between a 6-month intradialytic bicycling program and hospitalization rates and length of stay (LOS) in ESKD patients. This was a retrospective cohort study that took place 6 months prior to and 6 months during an intradialtyic exercise program at an outpatient HD unit in Calgary, Alberta, Canada. Participants comprised 102 patients who had commenced HD <6 months (incident) or >6 months (prevalent) prior to starting exercise. The intervention comprised a 6-month intradialytic bicycling program. Main outcome measures were hospitalization rate, cause of hospitalization, and LOS. Patients were predominantly male (67.6%) aged 65.6 ± 13.5 years and median HD vintage 1 year (range: 0-12). Comorbidities included diabetes mellitus (50%) and cardiac disease (38.2%). The hospitalization incidence rate ratio (IRR) was 0.48 (0.23-0.98; P = 0.04) in incident and 0.89 (0.56-1.42; P = 0.64) in prevalent patients. The LOS decreased from 7.8 (95% confidence interval (CI): 7.3-8.4) to 3.1 (95% CI: 2.8-3.4) days and LOS IRR was 0.39 (0.35-0.45; P < 0.001). The main predictors of hospitalization were lower albumin levels (P = 0.007) and lack of intradialytic exercise program participation (P < 0.001). In conclusion, 6 months of intradialytic exercise was associated with decreased LOS in both incident and prevalent HD patients.

Entities:  

Keywords:  durée du séjour; end-stage kidney disease; hospitalisation; hospitalization; length of stay; maladie rénale au stade terminal

Mesh:

Year:  2015        PMID: 25819883     DOI: 10.1139/apnm-2014-0326

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  6 in total

1.  Benefits and Barriers to and Desired Outcomes with Exercise in Patients with ESKD.

Authors:  Danielle Moorman; Rita Suri; Swapnil Hiremath; Januvi Jegatheswaran; Teerath Kumar; Ann Bugeja; Deborah Zimmerman
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-29       Impact factor: 8.237

2.  Impact of an intradialysis virtual-reality-based exercise program on healthcare resources expenditure: a micro-costing analysis.

Authors:  Alicia García-Testal; Francisco José Martínez-Olmos; Jose Antonio Gil-Gómez; Javier Villalón-Coca; Rafael Ortiz-Ramón; Alicia Cana-Poyatos; Rafael García-Maset; Eva Segura-Ortí
Journal:  BMC Nephrol       Date:  2022-06-27       Impact factor: 2.585

3.  Implementing a theory-based intradialytic exercise programme in practice: a quality improvement project.

Authors:  Hannah M L Young; Sushant Jeurkar; Darren R Churchward; Maurice Dungey; David J Stensel; Nicolette C Bishop; Sharlene A Greenwood; Sally J Singh; Alice C Smith; James O Burton
Journal:  Clin Kidney J       Date:  2018-07-05

Review 4.  Effects of intradialytic aerobic exercise on hemodialysis patients: a systematic review and meta-analysis.

Authors:  Nada Salhab; Mirey Karavetian; Jeroen Kooman; Enrico Fiaccadori; Cosette F El Khoury
Journal:  J Nephrol       Date:  2019-01-18       Impact factor: 3.902

5.  Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition.

Authors:  Nada Salhab; Mona Alrukhaimi; Jeroen Kooman; Enrico Fiaccadori; Harith Aljubori; Rana Rizk; Mirey Karavetian
Journal:  Nutrients       Date:  2019-10-15       Impact factor: 5.717

6.  A Cost-Effective Analysis of the CYCLE-HD Randomized Controlled Trial.

Authors:  Daniel S March; Adam W Hurt; Charlotte E Grantham; Darren R Churchward; Hannah M L Young; Patrick J Highton; Maurice Dungey; Nicolette C Bishop; Alice C Smith; Matthew P M Graham-Brown; Nicola J Cooper; James O Burton
Journal:  Kidney Int Rep       Date:  2021-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.